Rob Duncombe

The Christie NHS Foundation Trust
Director of Pharmacy

Rob Duncombe. Director of Pharmacy at the Christie NHS Foundation Trust in Manchester. A member of a number of national groups associated with pharmacy practice and medicines optimisation. Closely involved in recent initiates in the UK around the introduction of biosimilars in cancer; national dose banding of chemotherapy; and a radical approach to managing oral chemotherapy treatments.

dont miss

Medicine Optimisation in Oncology. How to achieve best value.

Expenditure on the drugs we use in cancer is increasing every year. This is a function of both demographics and a paradigm shift in how we treat cancer. It is therefore extremely important that we optimise the use of cancer medicines and eliminate waste.

EVEN MORE SEMINARS

  • Professor Patricia Price: Speaking at the Oncology Convention

    Professor Patricia Price
    Action Radiotherapy

    Action Radiotherapy -a charity for radiotherapy patients and professionals.

  • Cheng Boon: Speaking at the Oncology Convention

    Cheng Boon
    Worcestershire Royal Hospital

    Consultant Clinical Oncologist, GI and Head & Neck

  • Dr Christy Goldsmith: Speaking at the Oncology Convention

    Dr Christy Goldsmith
    Action Radiotherapy

    Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)

  • Prof Adam Waldman: Speaking at the Oncology Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma

  • Mohamed Torky: Speaking at the Oncology Convention

    Mohamed Torky
    Hospital Germans Trias i pujol. Barcelona. Spain

    Role of Radial-EBUS in diagnosis of lung cancer.